Reaction Details Report a problem with these data
Target
Nuclear receptor ROR-gamma [238-497]
Ligand
BDBM175908
Substrate
n/a
Meas. Tech.
TR-FRET Assay
pH
6.8±n/a
IC50
500±n/a nM
Comments
extracted
Citation
 Finsinger, D; Wucherer-Plietker, M; Blume, B Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors US Patent  US9688684 Publication Date 6/27/2017 
Target
Name:
Nuclear receptor ROR-gamma [238-497]
Synonyms:
NR1F3 | RORC | RORG | RORG_HUMAN | RZRG | Retinoid-related orphan receptor gamma (RORgamma-LBD)
Type:
Protein
Mol. Mass.:
29835.99
Organism:
Homo sapiens (Human)
Description:
Human RORgamma ligand-binding domain.
Residue:
260
Sequence:
HPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAA
  
Inhibitor
Name:
BDBM175908
Synonyms:
US9688684, Compound 105: 7-(3-Methyl-benzyl)-8-phenyl-5,6,7,8-tetrahydro-tetrazolo[1,5-a]pyrazine
Type:
Small organic molecule
Emp. Form.:
C18H19N5
Mol. Mass.:
305.377
SMILES:
Cc1cccc(CN2CCn3nnnc3C2c2ccccc2)c1
Structure:
Search PDB for entries with ligand similarity: